Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2025-12-24 @ 11:30 PM
NCT ID:
NCT02784756
Eligibility Criteria:
Inclusion Criteria:
* Adult kidney, kidney-pancreas, liver transplant recipient, or heart transplant recipient
* CMV D+/R- patient or any R+ patient who received antithymocyte globulin induction therapy
Exclusion Criteria:
* Unable to comply with protocol
* Campath (Alemtuzumab) induction
* Receiving another investigational compound for CMV treatment or prophylaxis.
* Allergy to valganciclovir or ganciclovir
* Receiving an investigational compound for prevention or treatment of rejection, or participating in another interventional study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02784756
Study Brief:
Protocol Section:
NCT02784756